Market capitalization | $2.91b |
Enterprise Value | $3.30b |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 93.98 |
EV/Sales (TTM) EV/Sales | 2.73 |
P/S ratio (TTM) P/S ratio | 2.41 |
P/B ratio (TTM) P/B ratio | 2.02 |
Revenue growth (TTM) Revenue growth | 20.08% |
Revenue (TTM) Revenue | $1.21b |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
6 Analysts have issued a LifeStance Health Group Inc forecast:
6 Analysts have issued a LifeStance Health Group Inc forecast:
Sep '24 |
+/-
%
|
||
Revenue | 1,206 1,206 |
20%
20%
|
|
Gross Profit | 298 298 |
46%
46%
|
|
EBITDA | 15 15 |
112%
112%
|
EBIT (Operating Income) EBIT | -63 -63 |
69%
69%
|
Net Profit | -95 -95 |
49%
49%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Lifestance Health Group, Inc. operates a holding company. The company was founded by Michael K. Lester, Gwen H. Booth and Danish J. Qureshi in 2017 and is headquartered in Scottsdale, AZ.
Head office | United States |
CEO | Ken Burdick |
Employees | 9,325 |
Founded | 2017 |
Website | lifestance.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.